Paul Aliu, head of Novartis' global governance office
Novartis' compassionate use requests worldwide: Just 0.5% came from lower-middle- and low-income countries
From 2018 through 2020, Novartis received almost 32,000 requests from 110 countries to use one of the company’s experimental drugs (known as “compassionate use” requests …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
